Dr. Brill + Partner prepares risk assessment
ICEBIO is a PhD network that will train the next generation of experts in glacier microbiology and biogeochemistry.
ICEBIO will provide a database of the functional diversity and potential of the glacier biome, which will not only greatly improve our understanding of a threatened biome, but also demonstrate the potential for exploiting economic and ecological services.
Dr. Brill + Partner GmbH will, among other things, provide a risk assessment regarding pathogenic organisms from the glacier biome, including the inclusion of bacteria, fungi, and viruses.
Further Information: https://www.icebio.eu/pages/project/index.html
The ICEBIO Doctoral Network is supported by a grant from the European Commission’s MSCA Doctoral Network program under project number 101072761
More News
Pacira BioSciences Acquires GQ Bio
HTGF portfolio company GQ Bio, pioneering a high-capacity adenovirus gene therapy vector platform, was acquired by Pacira BioSciences, Inc. Pacira, the industry leader in its ...
Read more …
CrystalsFirst Scales Operations...
CrystalsFirst, a leading provider of advanced structural biology solutions and AI-driven drug discovery, is pleased to announce a multi-million-euro expansion of its laboratory infrastructure and ...
Read more …
Strategic cornerstone for medac: FDA approves treosulfan for alloHSCT
medac has received FDA approval for treosulfan as a new drug application with orphan drug designation prior to allogeneic hematopoietic stem cell transplantation (alloHSCT) in ...
Read more …